clinical trials

Oni-Orisan given the Darrell Abernethy Early Stage Investigator Award

Thu Apr 30, 2020

Akinyemi Oni-Orisan, PharmD, PhD

Oni-Orisan was recognized for his contributions to clinical pharmacology.

Behind enemy lines

Wed Apr 18, 2018

UCSF

Sourav Bandyopadhyay, PhD, is senior author of the paper.

New research promises to take the guesswork out of matching individual cancer cases to the most effective choices of chemotherapy.

UCSF School of Pharmacy joins data-sharing partnership to speed cancer drugs

Thu Nov 2, 2017

Lawrence Livermore National Laboratory

A supercomputer in the Lawrence Livermore National Laboratory will be used in Project ATOM, a new public-private project that aims to speed discovery of new drug therapies.

A pioneering public/private consortium is poised to turn the marathon of drug discovery into a team relay, maybe even a short one.

Burchard leads call for diversity in research workforce

Thu Jun 16, 2016

Noah Berger

Marquitta White (right), MS, PhD, a postdoctoral fellow in the Burchard Lab, took on five young summer research students of diverse backgrounds, including Maria Contreras (left) and Oona Risse-Adams (center), a 16-year-old sophomore at Lowell High School in San Francisco.

The photograph of Martin Luther King Jr. hanging on the wall of the Asthma Collaboratory lab in UC San Francisco’s Rock Hall serves a reminder to all who toil there, purifying DNA samples or analyzing genetic, social or environmental data that their research is also part of a dream of equality and...

The Racial Discrimination Embedded in Modern Medicine

Mon Oct 26, 2015

Aweeka co-leads new study of drugs to prevent malaria in young children, pregnant women

Mon Mar 9, 2015

Image by Ute Frevert; false color by Margaret Shear

The plasmodium parasite that causes malaria

Francesca Aweeka, PharmD, a faculty member in the School’s Department of Clinical Pharmacy, will co-lead a new five-year, $3.4 million study funded by the National Institutes of Health (NIH) to address one of the world’s most vexing health problems—preventing malaria, especially in the most...

FDA launches UCSF-Stanford center for innovation in drug development, regulation

Mon May 5, 2014

Kathy Giacomini, PhD

The U.S. Food and Drug Administration (FDA) is tapping the UCSF School of Pharmacy and Stanford University to launch its first West Coast regulatory science center, focused on spurring innovation in the development and evaluation of safer and more effective medications.

Analysis finds sponsorship biases in animal studies may differ from those in clinical trials

Mon Jan 27, 2014

Cindy Chew

Lisa Bero, PhD

A new analysis of dozens of animal studies evaluating the effects of the cholesterol-lowering statin class of drugs on atherosclerosis found larger positive effects in studies not sponsored by the pharmaceutical industry as compared to those that were industry sponsored.

Study finds including unpublished FDA data alters drug effectiveness outcomes

Fri Jan 20, 2012

Lisa Bero, PhD

Every year U.S. drug regulators approve dozens of new medicines as “safe and effective,” but just how effective are they? How well do they alleviate specific aspects of illness, whether light sensitivity from migraine headaches or itching from eczema?

Giacomini cites increasing impact of quantitative pharmacology

Mon Oct 10, 2011